Gastro-esophageal Reflux in Asthmatic Patients.
10.4046/trd.1997.44.4.836
- Author:
Jung Kyung SUH
;
Kwang Ho LN
;
So Ra LEE
;
Sang Yeub LEE
;
Jae Youn CHO
;
Jae Jeong SHIM
;
Kyung Ho KANG
;
Se Hwa YOO
- Publication Type:Original Article
- Keywords:
Gastroesophageal reflux;
Bronchial asthma
- MeSH:
Asthma;
Cisapride;
Esophageal pH Monitoring;
Gastroesophageal Reflux*;
Humans;
Hydrogen-Ion Concentration;
Korea;
Prevalence
- From:Tuberculosis and Respiratory Diseases
1997;44(4):836-843
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The prevalence of Gastro-esophageal reflux(GER) in patients with asthma is estimated to be 50~60% and treatment of GER has been shown to improve asthma symptoms in Western. But GER has been known to be less common in Eastern and GER prevalence rates in asthmatics are not available in Korea. METHOD: We compared the prevalence rate of GER in 42 patients with asthma to that in 20 healthy normal controls and examed the efficacy of new prokinetic drug, cisapride(40mg/day, 8weeks) in patients with GER and asthma. For acid GER to be considered pathological, 24 hour esophageal pH monitoring should reveal values exceeding upper limit of 95 percentile for at least one of 6 parameter of DeMesseter's table. RESULT: The results showed GER was more common in patients with asthma(11/42, 26.2%) than normal controls(3/20, 15%) and asthmatics group showed a significant longer supine time pH<4(%) and total time pH<4(%), and more reflux episodes as compared with normal control group. After 4 asthmatics with GER were treated with cisapride, their asthma symtom scores, FEV1 and composite scores of pH monitoring were improved. CONCLUSION: GER is more common in asthmatics than in normal controls in Korea and prepulsid reduces asthma symptoms in patients with GER and asthma.
